Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article
Advertisement

Clinical Research and Public HealthIn-Press PreviewAIDS/HIVEndocrinology Open Access | 10.1172/jci.insight.195922

A distinct form of fat fibrosis is linked to insulin resistance in people with HIV

Diana L. Alba,1 Alaa Abdellatif,2 Moon K. Choi,3 Stephen M. Brown Mayfield,4 Thuy An T. Pham,4 David I. Berrios,4 Antonio E. Rodriguez,5 Marin Ewing,5 Tony R. Figueroa,5 Judy Gonzalez-Vargas,6 Ningyan Zhang,7 Zhiqiang An,7 Dawei Bu,8 Steven G. Deeks,5 Philipp E. Scherer,8 Peter W. Hunt,9 and Suneil K. Koliwad3

1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America

2University of California San Francisco Center for AIDS Research, San Francisco, United States of America

3Division of Endocrinology and Metabolism, UCSF, San Francisco, United States of America

4UCSF Diabetes Center, UCSF, San Francisco, United States of America

5Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America

6UCSF, San Francisco, United States of America

7Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medic, University of Texas Health Science Center at Houston, Houston, United States of America

8Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, United States of America

9Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America

Find articles by Alba, D. in: PubMed | Google Scholar

1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America

2University of California San Francisco Center for AIDS Research, San Francisco, United States of America

3Division of Endocrinology and Metabolism, UCSF, San Francisco, United States of America

4UCSF Diabetes Center, UCSF, San Francisco, United States of America

5Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America

6UCSF, San Francisco, United States of America

7Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medic, University of Texas Health Science Center at Houston, Houston, United States of America

8Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, United States of America

9Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America

Find articles by Abdellatif, A. in: PubMed | Google Scholar

1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America

2University of California San Francisco Center for AIDS Research, San Francisco, United States of America

3Division of Endocrinology and Metabolism, UCSF, San Francisco, United States of America

4UCSF Diabetes Center, UCSF, San Francisco, United States of America

5Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America

6UCSF, San Francisco, United States of America

7Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medic, University of Texas Health Science Center at Houston, Houston, United States of America

8Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, United States of America

9Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America

Find articles by Choi, M. in: PubMed | Google Scholar

1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America

2University of California San Francisco Center for AIDS Research, San Francisco, United States of America

3Division of Endocrinology and Metabolism, UCSF, San Francisco, United States of America

4UCSF Diabetes Center, UCSF, San Francisco, United States of America

5Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America

6UCSF, San Francisco, United States of America

7Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medic, University of Texas Health Science Center at Houston, Houston, United States of America

8Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, United States of America

9Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America

Find articles by Brown Mayfield, S. in: PubMed | Google Scholar

1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America

2University of California San Francisco Center for AIDS Research, San Francisco, United States of America

3Division of Endocrinology and Metabolism, UCSF, San Francisco, United States of America

4UCSF Diabetes Center, UCSF, San Francisco, United States of America

5Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America

6UCSF, San Francisco, United States of America

7Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medic, University of Texas Health Science Center at Houston, Houston, United States of America

8Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, United States of America

9Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America

Find articles by Pham, T. in: PubMed | Google Scholar

1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America

2University of California San Francisco Center for AIDS Research, San Francisco, United States of America

3Division of Endocrinology and Metabolism, UCSF, San Francisco, United States of America

4UCSF Diabetes Center, UCSF, San Francisco, United States of America

5Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America

6UCSF, San Francisco, United States of America

7Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medic, University of Texas Health Science Center at Houston, Houston, United States of America

8Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, United States of America

9Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America

Find articles by Berrios, D. in: PubMed | Google Scholar

1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America

2University of California San Francisco Center for AIDS Research, San Francisco, United States of America

3Division of Endocrinology and Metabolism, UCSF, San Francisco, United States of America

4UCSF Diabetes Center, UCSF, San Francisco, United States of America

5Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America

6UCSF, San Francisco, United States of America

7Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medic, University of Texas Health Science Center at Houston, Houston, United States of America

8Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, United States of America

9Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America

Find articles by Rodriguez, A. in: PubMed | Google Scholar

1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America

2University of California San Francisco Center for AIDS Research, San Francisco, United States of America

3Division of Endocrinology and Metabolism, UCSF, San Francisco, United States of America

4UCSF Diabetes Center, UCSF, San Francisco, United States of America

5Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America

6UCSF, San Francisco, United States of America

7Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medic, University of Texas Health Science Center at Houston, Houston, United States of America

8Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, United States of America

9Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America

Find articles by Ewing, M. in: PubMed | Google Scholar

1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America

2University of California San Francisco Center for AIDS Research, San Francisco, United States of America

3Division of Endocrinology and Metabolism, UCSF, San Francisco, United States of America

4UCSF Diabetes Center, UCSF, San Francisco, United States of America

5Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America

6UCSF, San Francisco, United States of America

7Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medic, University of Texas Health Science Center at Houston, Houston, United States of America

8Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, United States of America

9Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America

Find articles by Figueroa, T. in: PubMed | Google Scholar

1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America

2University of California San Francisco Center for AIDS Research, San Francisco, United States of America

3Division of Endocrinology and Metabolism, UCSF, San Francisco, United States of America

4UCSF Diabetes Center, UCSF, San Francisco, United States of America

5Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America

6UCSF, San Francisco, United States of America

7Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medic, University of Texas Health Science Center at Houston, Houston, United States of America

8Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, United States of America

9Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America

Find articles by Gonzalez-Vargas, J. in: PubMed | Google Scholar

1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America

2University of California San Francisco Center for AIDS Research, San Francisco, United States of America

3Division of Endocrinology and Metabolism, UCSF, San Francisco, United States of America

4UCSF Diabetes Center, UCSF, San Francisco, United States of America

5Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America

6UCSF, San Francisco, United States of America

7Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medic, University of Texas Health Science Center at Houston, Houston, United States of America

8Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, United States of America

9Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America

Find articles by Zhang, N. in: PubMed | Google Scholar

1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America

2University of California San Francisco Center for AIDS Research, San Francisco, United States of America

3Division of Endocrinology and Metabolism, UCSF, San Francisco, United States of America

4UCSF Diabetes Center, UCSF, San Francisco, United States of America

5Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America

6UCSF, San Francisco, United States of America

7Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medic, University of Texas Health Science Center at Houston, Houston, United States of America

8Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, United States of America

9Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America

Find articles by An, Z. in: PubMed | Google Scholar |

1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America

2University of California San Francisco Center for AIDS Research, San Francisco, United States of America

3Division of Endocrinology and Metabolism, UCSF, San Francisco, United States of America

4UCSF Diabetes Center, UCSF, San Francisco, United States of America

5Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America

6UCSF, San Francisco, United States of America

7Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medic, University of Texas Health Science Center at Houston, Houston, United States of America

8Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, United States of America

9Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America

Find articles by Bu, D. in: PubMed | Google Scholar

1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America

2University of California San Francisco Center for AIDS Research, San Francisco, United States of America

3Division of Endocrinology and Metabolism, UCSF, San Francisco, United States of America

4UCSF Diabetes Center, UCSF, San Francisco, United States of America

5Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America

6UCSF, San Francisco, United States of America

7Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medic, University of Texas Health Science Center at Houston, Houston, United States of America

8Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, United States of America

9Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America

Find articles by Deeks, S. in: PubMed | Google Scholar |

1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America

2University of California San Francisco Center for AIDS Research, San Francisco, United States of America

3Division of Endocrinology and Metabolism, UCSF, San Francisco, United States of America

4UCSF Diabetes Center, UCSF, San Francisco, United States of America

5Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America

6UCSF, San Francisco, United States of America

7Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medic, University of Texas Health Science Center at Houston, Houston, United States of America

8Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, United States of America

9Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America

Find articles by Scherer, P. in: PubMed | Google Scholar |

1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America

2University of California San Francisco Center for AIDS Research, San Francisco, United States of America

3Division of Endocrinology and Metabolism, UCSF, San Francisco, United States of America

4UCSF Diabetes Center, UCSF, San Francisco, United States of America

5Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America

6UCSF, San Francisco, United States of America

7Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medic, University of Texas Health Science Center at Houston, Houston, United States of America

8Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, United States of America

9Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America

Find articles by Hunt, P. in: PubMed | Google Scholar |

1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America

2University of California San Francisco Center for AIDS Research, San Francisco, United States of America

3Division of Endocrinology and Metabolism, UCSF, San Francisco, United States of America

4UCSF Diabetes Center, UCSF, San Francisco, United States of America

5Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America

6UCSF, San Francisco, United States of America

7Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medic, University of Texas Health Science Center at Houston, Houston, United States of America

8Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, United States of America

9Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America

Find articles by Koliwad, S. in: PubMed | Google Scholar |

Published June 30, 2026 - More info

JCI Insight. https://doi.org/10.1172/jci.insight.195922.
Copyright © 2026, Alba et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published June 30, 2026 - Version history
View PDF
Abstract

BACKGROUND. Despite antiretroviral therapy (ART), people with HIV (PWH) are at heightened risk for insulin resistance (IR) and type 2 diabetes (T2D). Subcutaneous adipose tissue (SAT) fibrosis contributes to metabolic disease, but its role in IR among PWH is unknown. We investigated the relationship between SAT fibrosis and IR in PWH, along with transcriptional signatures to distinguish it from SAT fibrosis due to obesity.

METHODS. We analyzed body composition and SAT fibrosis (hydroxyproline) in 46 PWH and 74 people without HIV (PWoH), excluding individuals with T2D. We examined fibrosis-related gene transcription in the SAT using a targeted panel and measured plasma endotrophin, a marker of extracellular matrix (ECM) remodeling.

RESULTS. PWH had substantially more SAT fibrosis than PWoH, notably in non-obese individuals. Moreover, SAT fibrosis in these PWH was strongly associated with IR, independently of prior legacy ART or ongoing integrase strand inhibitor treatment. This SAT fibrosis was highlighted by a distinct transcriptional pattern marked by upregulation of COL14A1, key immune-related genes (e.g., CCL4, NLRP3), and pathways governing ECM remodeling and immune activation, as well as downregulation of thermogenic, lipid metabolic, and insulin signaling pathways. Plasma endotrophin levels were also elevated in PWH and correlated independently with SAT fibrosis.

CONCLUSION. SAT fibrosis was associated with IR independent of obesity in PWH and was mirrored by circulating endotrophin levels, offering a plausible noninvasive biomarker for early intervention. The distinct transcriptional signature of HIV-associated SAT fibrosis highlights candidate mechanisms that may underlie metabolic risk and offer therapeutic avenues in this population.

Supplemental material

View

Version history
  • Version 1 (June 30, 2026): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts